«

»

Why You Can’t Find Cheap At-Home Covid Tests

While developing a rapid test that detects the coronavirus in someone’s saliva, Blink Science, a Florida-based startup, heard something startling: The Food and Drug Administration had more than 3,000 emergency use authorization applications and didn’t have the resources to get through them. “We want to try to avoid the EUA quagmire,” said Peb Hendrix, the startup’s vice president of operations. Its test is still in early development. On the advice of consultants, the company is weighing an alternative route through the FDA to the U.S. market. “It’s just the way our government works,” Hendrix said, which is a challenge for bu...

Read the full post at Syndicate – Kaiser Health News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive